Arecor Therapeutics plc (LON:AREC – Get Free Report) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 62.55 ($0.84) and last traded at GBX 65 ($0.87), with a volume of 16002 shares. The stock had previously closed at GBX 66 ($0.88).
Arecor Therapeutics Stock Down 1.5 %
The firm has a market capitalization of £24.54 million, a price-to-earnings ratio of -235.71 and a beta of -0.17. The company has a debt-to-equity ratio of 3.55, a quick ratio of 6.24 and a current ratio of 2.17. The business’s 50 day moving average is GBX 83.53 and its 200-day moving average is GBX 115.61.
About Arecor Therapeutics
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
Featured Stories
- Five stocks we like better than Arecor Therapeutics
- How to Plot Fibonacci Price Inflection Levels
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What Are Trending Stocks? Trending Stocks Explained
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
